#AskDrDurie

Learn about the latest myeloma research. Get a front row seat at the most critical medical meetings. Watch Dr. Brian Durie, IMF Chairman, address issues that are important to the entire myeloma community. IMF TV brings it all to you.

Jul
26
Can Kyprolis® (carfilzomib) be administered once a week, rather than twice a week?
In this week’s video, Dr. Brian G.M. Durie explains how the ARROW study demonstrated efficacy and low toxicity for weekly dosing of carfilzomib.
Jul
19
What are the immediate and long-term side effects of an autologous stem cell transplant (ASCT)?
In this video, Dr. Brian G.M. Durie explains how high-dose melphalan therapy that precedes an ASCT may cause some side effects and how an ASCT itself may result in some low-risk complications.
Jun
20
How does a myeloma patient’s lifestyle impact overall health?
In this video, Dr. Brian G.M. Durie explains which lifestyle choices can improve myeloma patients’ outcomes.
Jun
14
How does minimal residual disease (MRD) testing affect treatment decisions?
In this video, Dr. Brian G.M. Durie explains why MRD-negative status and MRD-positive status are not clear indicators for next steps in a myeloma patient’s treatment.
Jun
07
How can myeloma patients protect themselves from infections?
In this week’s video, Dr. Brian G.M. Durie recommends ways myeloma patients can avoid infections, such as using preventative antibiotics, getting certain vaccines, or using an air purifier. BOTTOM(...)
May
31
How much can myeloma patients learn from support groups?
In this week's video, Dr. Brian G.M. Durie discusses the ways patients can learn from one another at IMF-affiliated support groups. BOTTOM LINE: ​ Support groups are a great way to find out about(...)